Search Results - "Gibson, Alana"

GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis by Terrey, Markus, Adamson, Scott I, Gibson, Alana L, Deng, Tianda, Ishimura, Ryuta, Chuang, Jeffrey H, Ackerman, Susan L

“…Ribosome-associated quality control pathways respond to defects in translational elongation to recycle arrested ribosomes and degrade aberrant polypeptides and…”
Get full text

Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1 by Chandler, Randy J, Williams, Ian M, Gibson, Alana L, Davidson, Cristin D, Incao, Arturo A, Hubbard, Brandon T, Porter, Forbes D, Pavan, William J, Venditti, Charles P

“…Niemann-Pick disease, type C1 (NPC1) is a heritable lysosomal storage disease characterized by a progressive neurological degeneration that causes disability…”
Get full text

Maternal immune activation modifies the course of Niemann-pick disease, type C1 in a gender specific manner by Cougnoux, Antony, Fellmeth, Mason, Gu, Tansy, Davidson, Cristin D., Gibson, Alana L., Pavan, William J., Porter, Forbes D.

“…Niemann-Pick disease, type C1 (NPC1) is a rare neurodegenerative lysosomal storage disease with a wide spectrum of clinical manifestation. Multiple genetic…”
Get full text

Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice by Davidson, Cristin D, Gibson, Alana L, Gu, Tansy, Baxter, Laura L, Deverman, Benjamin E, Beadle, Keith, Incao, Arturo A, Rodriguez-Gil, Jorge L, Fujiwara, Hideji, Jiang, Xuntian, Chandler, Randy J, Ory, Daniel S, Gradinaru, Viviana, Venditti, Charles P, Pavan, William J

“…Niemann-Pick C1 disease (NPC1) is a rare, fatal neurodegenerative disease caused by mutations in , which encodes the lysosomal cholesterol transport protein…”
Get full text

Correction: GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis by Terrey, Markus, Adamson, Scott I, Gibson, Alana L, Deng, Tianda, Ishimura, Ryuta, Chuang, Jeffrey H, Ackerman, Susan L

Get full text

Gene therapy for the treatment of Niemann-Pick disease type C1: Comparison of AAV9 to a novel serotype, AAV-PHP.B by Davidson, Cristin, Gibson, Alana, Gu, Tansy, Chandler, Randy, Deverman, Benjamin, Gradinaru, Viviana, Venditti, Charles, Pavan, William

Get full text

Improved disease amelioration with combination therapy for Niemann-Pick disease type C1 by Davidson, Cristin, Gibson, Alana, Gu, Tansy, Ali, Nafeeza, Chandler, Randy, Venditti, Charles, Walkley, Steven U., Pavan, William

Get full text

Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy by Lypova, Nadiia, Lanceta, Lilibeth, Gibson, Alana, Vega, Stephanie, Garza-Morales, Rodolfo, McMasters, Kelly M, Chesney, Jason, Gomez-Gutierrez, Jorge G, Imbert-Fernandez, Yoannis

“…While clinical responses to palbociclib have been promising, metastatic breast cancer remains incurable due to the development of resistance. We generated…”
Get full text

613. A Comparison of CNS Transduction After Systemic versus Cranial Delivery of an AAV2/9 CamKII Promoter-eGFP Vector in Mice by Gibson, Alana L., Chandler, Randy J., Williams, Ian M., Incao, Arturo A., Porter, Forbes D., Pavan, William J., Venditti, Charles P.

Get full text